Aridis Pharmaceuticals Inc (NASDAQ:ARDS)

0.1791
Delayed Data
As of May 26
 -0.002 / -1.10%
Today’s Change
0.15
Today|||52-Week Range
2.77
-84.82%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$6.7M

Company Description

Aridis Pharmaceuticals, Inc. engages in the discovery and development of targeted immunotherapy using human monoclonal antibodies, or mAbs, to treat infections. The company was founded by Eric J. Patzer and Vu L. Truong on April 24, 2003 and is headquartered in Los Gatos, CA.

Contact Information

Aridis Pharmaceuticals, Inc.
983 University Avenue
Los Gatos California 95032
P:(408) 385-1742
Investor Relations:
(970) 987-2654

Employees

Shareholders

Other institutional9.05%
Individual stakeholders4.01%
Mutual fund holders3.07%

Top Executives

Vu L. TruongDirector, Chief Executive & Scientific Officer
Fred KurlandChief Financial Officer
Hasan JafriChief Medical Officer
Steven M. ChamowVice President-Research & Development
Lisa SherHead-Investor & Public Relations